212 related articles for article (PubMed ID: 31923585)
1. Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity.
Zafar S; Akhter S; Garg N; Selvapandiyan A; Kumar Jain G; Ahmad FJ
Eur J Pharm Biopharm; 2020 Mar; 148():10-26. PubMed ID: 31923585
[TBL] [Abstract][Full Text] [Related]
2. Improved chemotherapeutic efficacy against resistant human breast cancer cells with co-delivery of Docetaxel and Thymoquinone by Chitosan grafted lipid nanocapsules: Formulation optimization, in vitro and in vivo studies.
Zafar S; Akhter S; Ahmad I; Hafeez Z; Alam Rizvi MM; Jain GK; Ahmad FJ
Colloids Surf B Biointerfaces; 2020 Feb; 186():110603. PubMed ID: 31846892
[TBL] [Abstract][Full Text] [Related]
3. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J
J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039
[TBL] [Abstract][Full Text] [Related]
4. Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles.
Gao J; Liu J; Xie F; Lu Y; Yin C; Shen X
Int J Nanomedicine; 2019; 14():9199-9216. PubMed ID: 32063706
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel-loaded PAMAM-based poly (γ-benzyl-l-glutamate)-b-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles in human breast cancer and human cervical cancer therapy.
Wang Y; Zuo A; Huang X; Ying Y; Shu X; Chen X; Yang Y; Ma J; Lin G; Wang X; Mei L; Liu G; Zhao Y
J Microencapsul; 2019 Sep; 36(6):552-565. PubMed ID: 31403342
[TBL] [Abstract][Full Text] [Related]
6. Mixed Micelles of Doxorubicin Overcome Multidrug Resistance by Inhibiting the Expression of P-Glycoprotein.
Jin Y; Zhang Z; Zhao T; Liu X; Jian L
J Biomed Nanotechnol; 2015 Aug; 11(8):1330-8. PubMed ID: 26295136
[TBL] [Abstract][Full Text] [Related]
7. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
8. Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies.
Anwar M; Akhter S; Mallick N; Mohapatra S; Zafar S; Rizvi MMA; Ali A; Ahmad FJ
Pharmacol Res; 2016 Nov; 113(Pt A):146-165. PubMed ID: 27546165
[TBL] [Abstract][Full Text] [Related]
9. Exploring the Promising Potential of High Permeation Vesicle-Mediated Localized Transdermal Delivery of Docetaxel in Breast Cancer To Overcome the Limitations of Systemic Chemotherapy.
Bathara M; Date T; Chaudhari D; Ghadi R; Kuche K; Jain S
Mol Pharm; 2020 Jul; 17(7):2473-2486. PubMed ID: 32496783
[TBL] [Abstract][Full Text] [Related]
10. Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer.
Doddapaneni R; Patel K; Chowdhury N; Singh M
Sci Rep; 2017 Nov; 7(1):15824. PubMed ID: 29158480
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanocapsules co-encapsulating paclitaxel and salinomycin for eradicating breast cancer and cancer stem cells.
Basu SM; Yadava SK; Singh R; Giri J
Colloids Surf B Biointerfaces; 2021 Aug; 204():111775. PubMed ID: 33940518
[TBL] [Abstract][Full Text] [Related]
12. Encapsulating Halofuginone Hydrobromide in TPGS Polymeric Micelles Enhances Efficacy Against Triple-Negative Breast Cancer Cells.
Zuo R; Zhang J; Song X; Hu S; Gao X; Wang J; Ji H; Ji C; Peng L; Si H; Li G; Fang K; Zhang J; Jiang S; Guo D
Int J Nanomedicine; 2021; 16():1587-1600. PubMed ID: 33664573
[TBL] [Abstract][Full Text] [Related]
13. Roles of ligand and TPGS of micelles in regulating internalization, penetration and accumulation against sensitive or resistant tumor and therapy for multidrug resistant tumors.
Wang AT; Liang DS; Liu YJ; Qi XR
Biomaterials; 2015 Jun; 53():160-72. PubMed ID: 25890716
[TBL] [Abstract][Full Text] [Related]
14. Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers.
Kutty RV; Feng SS
Biomaterials; 2013 Dec; 34(38):10160-71. PubMed ID: 24090836
[TBL] [Abstract][Full Text] [Related]
15. Switching indication of PEGylated lipid nanocapsules-loaded with rolapitant and deferasirox against breast cancer: Enhanced in-vitro and in-vivo cytotoxicity.
Kabil MF; Mahmoud MY; Bakr AF; Zaafar D; El-Sherbiny IM
Life Sci; 2022 Sep; 305():120731. PubMed ID: 35753435
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment.
Tang X; Liang Y; Feng X; Zhang R; Jin X; Sun L
Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():348-355. PubMed ID: 25686959
[TBL] [Abstract][Full Text] [Related]
18. A polypeptide based podophyllotoxin conjugate for the treatment of multi drug resistant breast cancer with enhanced efficiency and minimal toxicity.
Zhou H; Lv S; Zhang D; Deng M; Zhang X; Tang Z; Chen X
Acta Biomater; 2018 Jun; 73():388-399. PubMed ID: 29694920
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance.
Dong K; Yan Y; Wang P; Shi X; Zhang L; Wang K; Xing J; Dong Y
Int J Nanomedicine; 2016; 11():5109-5123. PubMed ID: 27785018
[TBL] [Abstract][Full Text] [Related]
20. Tuning mPEG-PLA/vitamin E-TPGS-based mixed micelles for combined celecoxib/honokiol therapy for breast cancer.
Sun J; Li J; Liu Q; Jiang M; Yang M; Zhan S; Qiu T; He K; Zhang X
Eur J Pharm Sci; 2020 Apr; 146():105277. PubMed ID: 32105783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]